Alnylam Pharmaceuticals reported $605.96M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
Alnylam Pharmaceuticals ALNY:US $ 605.96M 89.75M
Amgen AMGN:US $ 12886M 702M
Arrowhead Research ARWR:US $ 138.86M 1.82M
Avrobio Inc AVRO:US $ 17.13M 2.26M
Biocryst Pharmaceuticals BCRX:US $ 81.02M 22.7M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Moderna Inc MRNA:US 9.24B 110M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Novartis NVS:US $ 29807M 401M
Ptc Therapeutics PTCT:US $ 476.78M 32.57M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Regulus Therapeutics RGLS:US $ 4.7M 0.53M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Sarepta Therapeutics SRPT:US $ 454.96M 2.23M
Takeda 4502:JP Y 2145730M 336476M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M
Xencor XNCR:US $ 60.94M 9.8M
YTE INCY:US $ 886.16M 31.86M